Nanome Case Studies
Learn why innovative Pharma companies and research institutions like Novartis, Nimbus, LifeArc, and UCSD are using Nanome to accelerate their drug discovery research.
- intuitively visualize and interact with chemical compounds in 3D
- collaborate on drug design
- communicate with stakeholders
Nanome 1.24 in a nutshell
"A virtual and mixed reality platform for molecular design & drug
discovery - Nanome version 1.24"
A manuscript to describe in depth all the changes adopted in Nanome 1.24 and the advantages that it brings to scientific discovery. The work has been presented at the 5th Workshop on Molecular Graphics and Visual Analysis of Molecular Data (MolVa) in Leipzig.
“Visualization in real 3D versus a flat screen transforms things, and it helps accelerate the process of discovery.”
“I would call it accelerated template-based drug design, it's accelerated because one can get into that molecule and instantaneously recognize what [ligand] fits and what does not fit."
Molecular dynamics simulations of computationally modeled spike protein in complex with ACE2 receptor were analyzed in VR to evaluate the effects of mutations in SARS-CoV-2 variants of concern